Hayon Yael - Insider Non-Derivative Transactions at Protalix BioTherapeutics, Inc. (PLX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 15, 2023, Hayon Yael's relationship to Protalix BioTherapeutics, Inc. (PLX) is Officer (VP, Research & Development), and currently has 35,115 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PLX insiders.
Data Source: SEC.
Hayon Yael - Insider Non-Derivative Transactions at PLX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 16, 2023 | Acquisition -- (Common Stock) | 35115 | 0 | 35115 |